{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:06:19Z","timestamp":1785891979522,"version":"3.56.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004507","name":"Central Drug Research Institute","doi-asserted-by":"publisher","award":["DMI6000"],"award-info":[{"award-number":["DMI6000"]}],"id":[{"id":"10.13039\/501100004507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Pathology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.carpath.2022.107468","type":"journal-article","created":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T01:27:17Z","timestamp":1660526837000},"page":"107468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Aurintricarboxylic acid protects isoproterenol induced left ventricular hypertrophy by modulating TWEAK signaling"],"prefix":"10.1016","volume":"61","author":[{"given":"Prabha","family":"Burman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kusum","family":"Devi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0098-6135","authenticated-orcid":false,"given":"Baisakhi","family":"Moharana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carpath.2022.107468_bib0001","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nature Reviews Cardiology"},{"key":"10.1016\/j.carpath.2022.107468_bib0002","unstructured":"WHO. Cardiovascular diseases (CVDs). 2019."},{"key":"10.1016\/j.carpath.2022.107468_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-018-1137-1","article-title":"Soluble TNF-like weak inducer of apoptosis (TWEAK) enhances poly (I: C)-induced RIPK1-mediated necroptosis","volume":"9","author":"Anany","year":"2018","journal-title":"Cell Death & Disease"},{"key":"10.1016\/j.carpath.2022.107468_bib0004","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1038\/onc.2015.310","article-title":"The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeutics","volume":"35","author":"Perez","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.carpath.2022.107468_bib0005","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1161\/CIRCULATIONAHA.108.837286","article-title":"A novel role for tumor necrosis factor\u2013like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failure","volume":"119","author":"Jain","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2022.107468_bib0006","doi-asserted-by":"crossref","first-page":"6433","DOI":"10.4049\/jimmunol.177.9.6433","article-title":"Involvement of TNF-like weak inducer of apoptosis in the pathogenesis of collagen-induced arthritis","volume":"177","author":"Kamata","year":"2006","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.carpath.2022.107468_bib0007","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.4049\/jimmunol.177.4.2610","article-title":"TWEAK is a novel arthritogenic mediator","volume":"177","author":"Perper","year":"2006","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.carpath.2022.107468_bib0008","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.clim.2005.06.005","article-title":"Anti-TWEAK monoclonal antibodies reduce immune cell infiltration in the central nervous system and severity of experimental autoimmune encephalomyelitis","volume":"117","author":"Desplat-J\u00e9go","year":"2005","journal-title":"Clinical Immunology"},{"key":"10.1016\/j.carpath.2022.107468_bib0009","doi-asserted-by":"crossref","first-page":"8237","DOI":"10.1523\/JNEUROSCI.1089-04.2004","article-title":"Tumor necrosis factor-like weak inducer of apoptosis-induced neurodegeneration","volume":"24","author":"Potrovita","year":"2004","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.carpath.2022.107468_bib0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/ki.2010.379","article-title":"Direct targeting of fibroblast growth factor-inducible 14 protein protects against renal ischemia reperfusion injury","volume":"79","author":"Hotta","year":"2011","journal-title":"Kidney International"},{"key":"10.1016\/j.carpath.2022.107468_bib0011","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1161\/ATVBAHA.109.194852","article-title":"Tumor necrosis factor\u2013like weak inducer of apoptosis (TWEAK) enhances vascular and renal damage induced by hyperlipidemic diet in ApoE-knockout mice","volume":"29","author":"Munoz-Garcia","year":"2009","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.carpath.2022.107468_bib0012","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.clinthera.2013.06.008","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of anti-TWEAK monoclonal antibody in patients with rheumatoid arthritis","volume":"35","author":"Wisniacki","year":"2013","journal-title":"Clinical therapeutics"},{"key":"10.1016\/j.carpath.2022.107468_bib0013","series-title":"Molecular Cancer Therapeutics","article-title":"Abstract C18: A phase I study of enavatuzumab (PDL192, ABT-361), a first-in-class human monoclonal antibody targeting TWEAK (tumor necrosis factor-like inducer of apoptosis) receptor, in patients (Pts) with advanced solid tumors","author":"Lam","year":"2011"},{"key":"10.1016\/j.carpath.2022.107468_bib0014","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/0006-291X(73)91198-4","article-title":"The inhibition of nucleic acid-binding proteins by aurintricarboxylic acid","volume":"55","author":"Blumenthal","year":"1973","journal-title":"Biochem Biophysi Res Commun"},{"key":"10.1016\/j.carpath.2022.107468_bib0015","doi-asserted-by":"crossref","first-page":"12234","DOI":"10.18632\/oncotarget.14685","article-title":"Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells","volume":"8","author":"Roos","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.carpath.2022.107468_bib0016","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/SHK.0000000000000128","article-title":"Salutary effect of aurintricarboxylic acid (ATA) on endotoxin-and sepsis-induced changes in muscle protein synthesis and inflammation","volume":"41","author":"Laufenberg","year":"2014","journal-title":"Shock"},{"key":"10.1016\/j.carpath.2022.107468_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184153","article-title":"E2\/ER \u03b2 inhibit ISO-induced cardiac cellular hypertrophy by suppressing Ca2+-calcineurin signaling","volume":"12","author":"Tsai","year":"2017","journal-title":"PloS one"},{"key":"10.1016\/j.carpath.2022.107468_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-11-130","article-title":"A proteomic view of isoproterenol induced cardiac hypertrophy: prohibitin identified as a potential biomarker in rats","volume":"11","author":"Chowdhury","year":"2013","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/j.carpath.2022.107468_bib0019","first-page":"68","article-title":"Anti-inflammatory effect of aluminum or aurin tricarboxylic acid","volume":"174","author":"Allain","year":"1980","journal-title":"Comptes Rendus Seances Societe Biologie Ses Filiales"},{"key":"10.1016\/j.carpath.2022.107468_bib0020","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1089\/jop.1995.11.253","article-title":"The effect of aurintricarboxylic acid, an endonuclease inhibitor, on ischemia\/reperfusion damage in rat retina","volume":"11","author":"Lam","year":"1995","journal-title":"J Ocular Pharmacol Therap"},{"key":"10.1016\/j.carpath.2022.107468_bib0021","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s10741-007-9007-4","article-title":"Cardiac hypertrophy induced by sustained \u03b2-adrenoreceptor activation: pathophysiological aspects","volume":"12","author":"Osadchii","year":"2007","journal-title":"Heart Failure Review"},{"key":"10.1016\/j.carpath.2022.107468_bib0022","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1152\/physiolgenomics.90297.2008","article-title":"Myoglobin-deficient mice activate a distinct cardiac gene expression program in response to isoproterenol-induced hypertrophy","volume":"41","author":"Molojavyi","year":"2010","journal-title":"Physiological Genomics"},{"key":"10.1016\/j.carpath.2022.107468_bib0023","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3389\/fimmu.2013.00447","article-title":"TWEAK\/Fn14 and non-canonical NF-kappaB signaling in kidney disease","volume":"4","author":"Poveda","year":"2013","journal-title":"Frontiers in immunology"},{"key":"10.1016\/j.carpath.2022.107468_bib0024","doi-asserted-by":"crossref","first-page":"H1655","DOI":"10.1152\/ajpheart.00756.2011","article-title":"Cardiac-specific genetic inhibition of nuclear factor-\u03baB prevents right ventricular hypertrophy induced by monocrotaline","volume":"302","author":"Kumar","year":"2012","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"key":"10.1016\/j.carpath.2022.107468_bib0025","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1080\/01926230701194211","article-title":"Aurintricarboxylic acid inhibits protein synthesis independent, sanguinarine-induced apoptosis and oncosis","volume":"35","author":"Hallock","year":"2007","journal-title":"Toxicologic pathology"},{"key":"10.1016\/j.carpath.2022.107468_bib0026","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1136\/hrt.2005.068270","article-title":"Oxidative stress and redox signalling in cardiac hypertrophy and heart failure","volume":"93","author":"Seddon","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.carpath.2022.107468_bib0027","first-page":"1998","article-title":"TWEAK\/Fn14 promotes oxidative stress through AMPK\/PGC\u20111\u03b1\/MnSOD signaling pathway in endothelial cells","volume":"17","author":"Liu","year":"2018","journal-title":"Molecular Medicine Reports"},{"key":"10.1016\/j.carpath.2022.107468_bib0028","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/cvr\/cvv204","article-title":"TWEAK\/Fn14 interaction promotes oxidative stress through NADPH oxidase activation in macrophages","volume":"108","author":"Madrigal","year":"2015","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.carpath.2022.107468_bib0029","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/hc0302.103712","article-title":"Pivotal role of a gp91phox-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice","volume":"105","author":"Bendall","year":"2002","journal-title":"Circulation"}],"container-title":["Cardiovascular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105488072200062X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105488072200062X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:41:59Z","timestamp":1778586119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105488072200062X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":29,"alternative-id":["S105488072200062X"],"URL":"https:\/\/doi.org\/10.1016\/j.carpath.2022.107468","relation":{},"ISSN":["1054-8807"],"issn-type":[{"value":"1054-8807","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aurintricarboxylic acid protects isoproterenol induced left ventricular hypertrophy by modulating TWEAK signaling","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carpath.2022.107468","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107468"}}